| 包装: | 1mg |
| 规格: | 98% |
| 市场价: | 16669元 |
| 分子量: | 361.4 |
Background:
Trelagliptin-13C-d3is intended for use as an internal standard for the quantification of trelagliptin by GC- or LC-MS. Trelagliptin is an inhibitor of dipeptidyl peptidase 4 (DPP-4; IC50= 4 nM).1It is greater than 10,000-fold selective for DPP-4 over isopeptidases. Trelagliptin (7 mg/kg) inhibits plasma DPP-4 activity and reduces postprandial plasma insulin levels in Zuckerfa/farats. Formulations containing trelagliptin have been used in the treatment of type 2 diabetes mellitus.
1.Kushwaha, R.N., Haq, W., and Katti, S.B.Discovery of 17 gliptins in 17-years of research for the treatment of type 2 diabetes: A synthetic overviewChemistry and Biology Interface4(3)137-162(2014)
m.cnreagent.com